Zhangzhou Pientzehuang Pharmaceutical Co Ltd - Asset Resilience Ratio
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has an Asset Resilience Ratio of 17.40% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Zhangzhou Pientzehuang Pharmaceutical Co balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2003–2024)
This chart shows how Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See net assets of Zhangzhou Pientzehuang Pharmaceutical Co for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Zhangzhou Pientzehuang Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600436 company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥3.26 Billion | 17.4% |
| Total Liquid Assets | CN¥3.26 Billion | 17.40% |
Asset Resilience Insights
- Good Liquidity Position: Zhangzhou Pientzehuang Pharmaceutical Co Ltd maintains a healthy 17.40% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhangzhou Pientzehuang Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Novartis AG
MX:NVSN |
Drug Manufacturers - General | 0.09% |
|
Novo Nordisk A/S
CO:NOVO-B |
Drug Manufacturers - General | 0.09% |
|
Novartis AG
SW:NOVN |
Drug Manufacturers - General | 10.04% |
|
Pfizer Inc
SA:PFIZ34 |
Drug Manufacturers - General | 7.18% |
|
Firebrick Pharma Ltd
AU:FRE |
Drug Manufacturers - General | 0.29% |
|
Eli Lilly and Company
SA:LILY34 |
Drug Manufacturers - General | 8.63% |
|
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3 |
Drug Manufacturers - General | 10.10% |
|
Sichuan Kelun Pharmaceutical Co Ltd
SHE:002422 |
Drug Manufacturers - General | 3.76% |
Annual Asset Resilience Ratio for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2003–2024)
The table below shows the annual Asset Resilience Ratio data for Zhangzhou Pientzehuang Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 20.07% | CN¥3.52 Billion ≈ $515.03 Million |
CN¥17.54 Billion ≈ $2.57 Billion |
-33.14pp |
| 2023-12-31 | 53.21% | CN¥9.09 Billion ≈ $1.33 Billion |
CN¥17.08 Billion ≈ $2.50 Billion |
+53.14pp |
| 2021-12-31 | 0.07% | CN¥8.80 Million ≈ $1.29 Million |
CN¥12.50 Billion ≈ $1.83 Billion |
+0.07pp |
| 2020-12-31 | 0.00% | CN¥13.37K ≈ $1.96K |
CN¥10.21 Billion ≈ $1.49 Billion |
0.00pp |
| 2019-12-31 | 0.00% | CN¥19.22K ≈ $2.81K |
CN¥8.81 Billion ≈ $1.29 Billion |
0.00pp |
| 2018-12-31 | 0.00% | CN¥46.84K ≈ $6.85K |
CN¥6.66 Billion ≈ $974.24 Million |
+0.00pp |
| 2017-12-31 | 0.00% | CN¥24.29K ≈ $3.55K |
CN¥5.65 Billion ≈ $826.52 Million |
0.00pp |
| 2016-12-31 | 0.00% | CN¥134.97K ≈ $19.75K |
CN¥5.04 Billion ≈ $737.19 Million |
+0.00pp |
| 2013-12-31 | 0.00% | CN¥42.56K ≈ $6.23K |
CN¥3.26 Billion ≈ $476.94 Million |
+0.00pp |
| 2011-12-31 | 0.00% | CN¥838.64 ≈ $122.72 |
CN¥1.57 Billion ≈ $229.55 Million |
-0.01pp |
| 2010-12-31 | 0.01% | CN¥94.31K ≈ $13.80K |
CN¥1.45 Billion ≈ $211.72 Million |
-0.39pp |
| 2009-12-31 | 0.39% | CN¥5.05 Million ≈ $738.37K |
CN¥1.28 Billion ≈ $187.97 Million |
+0.05pp |
| 2006-12-31 | 0.34% | CN¥2.49 Million ≈ $364.22K |
CN¥730.62 Million ≈ $106.91 Million |
-0.74pp |
| 2005-12-31 | 1.09% | CN¥7.53 Million ≈ $1.10 Million |
CN¥693.63 Million ≈ $101.50 Million |
-1.93pp |
| 2004-12-31 | 3.01% | CN¥16.83 Million ≈ $2.46 Million |
CN¥558.77 Million ≈ $81.77 Million |
-18.31pp |
| 2003-12-31 | 21.32% | CN¥126.88 Million ≈ $18.57 Million |
CN¥594.99 Million ≈ $87.07 Million |
-- |
About Zhangzhou Pientzehuang Pharmaceutical Co Ltd
Zhangzhou Pientzehuang Pharmaceutical., Ltd, together with its subsidiaries, manufactures and distributes pharmaceuticals and cosmetics in China and internationally. It offers Chinese medicines in various forms, including capsules, tablets, pills, syrups, and ointments, as well as health care food and functional drinks, special efficacy cosmetics, and household chemicals under the Pien Tze Huang … Read more